| |
| |
|
| Insider
Information: |
Lange Louis G |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
582,756 |
|
|
Indirect Shares
|
228,940 |
|
|
| Direct
Value |
$85,444 |
|
|
|
Indirect Value
|
$427,038 |
|
|
| Total
Shares |
811,696 |
|
|
| Total
Value |
$512,483 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
CV Therapeutics Inc |
CVTX |
Chairman & CEO, Director |
2009-04-09 |
483,618 |
2009-04-09 |
6,359 |
Premium* |
|
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
60,000 |
2009-09-22 |
0 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
Director |
2013-07-01 |
17,814 |
2013-07-01 |
197,703 |
Premium* |
|
|
Cymabay Therapeutics, Inc. |
CBAY |
Director |
2013-10-11 |
1,446 |
|
0 |
Premium* |
|
|
Newamsterdam Pharma Ord Shs |
NAMS |
|
2023-12-29 |
19,878 |
2024-02-13 |
24,878 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2008-03-24 |
4 |
D |
$7.31 |
$36,426 |
D/D |
(4,983) |
270,919 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman and CEO |
• • – |
2003-10-31 |
4 |
OE |
$7.50 |
$37,500 |
D/D |
5,000 |
105,184 |
|
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2008-06-23 |
4 |
D |
$8.39 |
$42,168 |
D/D |
(5,026) |
277,239 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2008-12-11 |
4 |
OE |
$8.48 |
$101,760 |
D/D |
12,000 |
304,325 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2008-12-11 |
4 |
D |
$8.48 |
$46,555 |
D/D |
(5,490) |
298,835 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-05-17 |
4 |
A |
$8.55 |
$9,243 |
D/D |
1,081 |
202,188 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-08-17 |
4 |
A |
$8.55 |
$6,549 |
D/D |
766 |
209,274 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-03-22 |
4 |
D |
$8.80 |
$34,232 |
D/D |
(3,890) |
201,107 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2008-12-22 |
4 |
OE |
$8.91 |
$101,093 |
D/D |
11,346 |
305,728 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2008-12-22 |
4 |
D |
$8.91 |
$44,782 |
D/D |
(5,026) |
305,115 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2008-01-10 |
4 |
D |
$8.93 |
$3,197 |
D/D |
(358) |
251,688 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2004-05-20 |
4 |
OE |
$9.25 |
$4,625 |
D/D |
500 |
105,273 |
|
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2006-08-23 |
4 |
OE |
$9.25 |
$231,250 |
D/D |
25,000 |
134,286 |
|
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-03-08 |
4 |
OE |
$9.25 |
$185,000 |
D/D |
20,000 |
193,652 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-09-24 |
4 |
D |
$9.25 |
$46,491 |
D/D |
(5,026) |
215,594 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-12-24 |
4 |
D |
$9.25 |
$46,481 |
D/D |
(5,025) |
251,209 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2009-01-15 |
4 |
OE |
$9.33 |
$7,473 |
D/D |
801 |
305,916 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2009-01-15 |
4 |
D |
$9.33 |
$2,668 |
D/D |
(286) |
305,630 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-12-11 |
4 |
D |
$9.40 |
$51,606 |
D/D |
(5,490) |
244,889 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-12-11 |
4 |
A |
$9.40 |
$112,800 |
D/D |
12,000 |
250,379 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-12-05 |
4 |
A |
$9.50 |
$114,000 |
D/D |
12,000 |
243,869 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-12-05 |
4 |
D |
$9.50 |
$52,155 |
D/D |
(5,490) |
238,379 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2008-12-09 |
4 |
OE |
$9.51 |
$114,120 |
D/D |
12,000 |
297,646 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2008-12-09 |
4 |
D |
$9.51 |
$52,210 |
D/D |
(5,490) |
292,325 |
0 |
- |
|
| CVTX |
CV Therapeutics Inc |
Chairman & CEO |
• • – |
2007-11-09 |
4 |
D |
$10.12 |
$138,897 |
D/D |
(13,725) |
231,869 |
0 |
- |
|
68 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
